Efficacy and safety of lactosaminated human serum albumin-adenine arabinoside monophosphate in chronic hepatitis B patients non-responders to interferon therapy: a randomised clinical trial
- PMID: 11322216
- DOI: 10.1016/s0168-8278(01)00018-6
Efficacy and safety of lactosaminated human serum albumin-adenine arabinoside monophosphate in chronic hepatitis B patients non-responders to interferon therapy: a randomised clinical trial
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources